Document Detail


Selective large coronary endothelial dysfunction in conscious dogs with chronic coronary pressure overload.
MedLine Citation:
PMID:  9486258     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Coronary vascular responses to acetylcholine (ACh, 3 micrograms/kg i.v.), nitroglycerin (NTG, 25 micrograms/kg i.v.), and a 20-s coronary artery occlusion (reactive hyperemia, RH) were investigated in seven conscious dogs with severe left ventricular (LV) hypertrophy and chronic coronary pressure overload (CCPO) due to supravalvular aortic banding and in seven control dogs. All dogs were instrumented for measurement of ultrasonic coronary diameter (CD) and Doppler coronary blood flow (CBF). LV-to-body weight ratio was increased by 82% in CCPO dogs. In control dogs, ACh increased CD (+ 5.9 +/- 1.7%). This response was reduced (P < 0.05) in CCPO dogs (+ 1.9 +/- 0.9%). Similarly, flow-mediated increases in CD after RH were blunted (P < 0.01) in CCPO (+ 2.1 +/- 0.8) vs. control dogs (+ 6.8 +/- 1.8%). In contrast, ACh and RH increased CBF similarly in both groups. Increases in both CD and CBF to NTG were not different between control dogs and CCPO. Peak systolic CBF velocity was greater, P < 0.01, in CCPO (94 +/- 17 cm/s) compared with control (35 +/- 7 cm/s) dogs, most likely secondary to the increased systolic coronary perfusion pressure (215 vs. 130 mmHg). Histological analyses of large coronary arteries in CCPO revealed medial thickening, intimal thickening, and disruption of the internal elastic lamina and endothelium. In contrast, small intramyocardial arterioles failed to show the intimal and endothelial lesions. Thus, in CCPO selective to the coronary arteries, i.e., a model independent from systemic hypertension and enhanced levels of plasma renin activity, endothelial control was impaired for both flow-mediated and receptor-mediated large coronary artery function, which could be accounted for by the major morphological changes in the large coronary arteries sparing the resistance vessels. The mechanism may involve chronically elevated systolic coronary perfusion pressure, CBF velocity, and potential disruption of laminar flow patterns.
Authors:
B Ghaleh; L Hittinger; S J Kim; R K Kudej; M Iwase; M Uechi; A Berdeaux; S P Bishop; S F Vatner
Related Documents :
2373828 - Preservation of ventricular function by treatment of ventricular fibrillation with phen...
3680788 - Effects of histamine on coronary hemodynamics in humans: role of h1 and h2 receptors.
11548878 - Determination of coronary zero flow pressure by analysis of the baseline pressure-flow ...
7251868 - Comparison of acute alterations in left ventricular relaxation and diastolic chamber st...
21861568 - Methanol nucleation in a supersonic nozzle.
19871118 - An inquiry into the structural conditions affecting fluid transport in the interstitial...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of physiology     Volume:  274     ISSN:  0002-9513     ISO Abbreviation:  Am. J. Physiol.     Publication Date:  1998 Feb 
Date Detail:
Created Date:  1998-03-17     Completed Date:  1998-03-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370511     Medline TA:  Am J Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  H539-51     Citation Subset:  IM; S    
Affiliation:
Cardiovascular and Pulmonary Research Institute, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcholine / pharmacology
Animals
Blood Flow Velocity
Blood Pressure
Constriction
Coronary Vessels / drug effects,  pathology,  physiopathology*
Dogs
Endothelium, Vascular / physiopathology*
Female
Hemodynamics
Hyperemia / etiology,  physiopathology
Hypertrophy, Left Ventricular / pathology,  physiopathology*
Male
Microscopy, Electron, Scanning
Nitroglycerin / pharmacology
Vasodilator Agents / pharmacology
Grant Support
ID/Acronym/Agency:
HL-33065/HL/NHLBI NIH HHS; HL-33107/HL/NHLBI NIH HHS; P01 HL-59139/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 51-84-3/Acetylcholine; 55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Downregulation of 5'-nucleotidase in rabbit heart during coronary underperfusion.
Next Document:  Mitral valve opening in the ovine heart.